Merck's Cholesterol Pill Win Is Already Drawing Fire
The Food and Drug Administration just approved Liptruzet, a new cholesterol-lowering pill that combines the generically available ingredient available in Pfizer's Lipitor with Merck's Zetia. Merck has been working to get the combination pill approved for several years -- and one critic is already saying it was a mistake to approve the combination drug.
Source: Forbes.com Healthcare News - Category: Pharmaceuticals Authors: Matthew Herper Source Type: news
More News: Atorvastatin Calcium | Cholesterol | Food and Drug Administration (FDA) | Lipitor | Merck | Pfizer | Pharmaceuticals | Statin Therapy | Zetia | Zivast